Renvio, the leading EMR platform for independent dialysis providers, today announced a strategic partnership with Klinrisk, a leader in predictive AI for chronic disease. This collaboration will power the next generation of AI-enabled tools for kidney care—starting with Hospitalization Prediction and Clinical Decision Support—natively integrated within Renvio’s Dialysis Manager EMR at the point of care.

As kidney care continues to shift toward value-based models, Renvio and Klinrisk are charting a new path: delivering intelligent insights where and when care happens. Unlike legacy AI vendors or bolt-on solutions, the Renvio-Klinrisk partnership enables clinicians to act on AI-driven recommendations without leaving their workflow—making predictive insights not only accessible but actionable.

“Klinrisk brings world-class AI capabilities, and Renvio brings the context,” said Chris Sigala, CEO of Renvio. “This partnership is about more than prediction—it’s about empowering clinicians to take the right action, at the right time, in the flow of care. That’s the future of intelligent kidney care.”

By embedding advanced risk stratification and recommended clinical workflows directly into the Renvio EMR, Renvio’s Clinical AI solutions will support real-time clinical interventions, medication optimization, and care coordination for patients with end stage renal disease (ESRD). A key feature of the Clinical AI will be to always keep the nephrologist in the loop. Early pilots will target reduction of preventable hospitalizations—a key driver of cost and poor outcomes in kidney populations.

This announcement positions Renvio as the first EMR in kidney care to offer a fully embedded AI engine, tightly aligned with clinician workflows. It also underscores the company’s broader vision to build the most intelligent operating system in value-based kidney care.

“We’re thrilled to partner with Renvio to put predictive intelligence directly in the hands of providers ,” said Dr. Navdeep Tangri, CEO of Klinrisk. “Together, we’re making AI not just smart—but actionable at the point of care.”

Renvio and Klinrisk will debut their first integrated models with select provider groups later this year, with broader availability expected in early 2026.